Importantly, CBD pathology is observed not only in CBS (~50%) but also in PSP-RS, Alzheimer's disease (AD), frontal temporal lobar degeneration (FTLD), and Creutzfeldt–Jakob disease (64). This evidence concerns the gene CBS and early-onset autosomal dominant Alzheimer disease.